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Abstract
A total of twenty-four sows and their offspring were used in a 20-week study to investigate the effects of feeding GM maize on maternal
and offspring health. Sows were fed diets containing GM or non-GM maize from service to the end of lactation. GM maize-fed sows were
heavier on day 56 of gestation (P,0·05). Offspring from sows fed GM maize tended to be lighter at weaning (P¼0·08). Sows fed GM maize
tended to have decreased serum total protein (P¼0·08), and increased serum creatinine (P,0·05) and g-glutamyltransferase activity
(P¼0·07) on day 28 of lactation. Serum urea tended to be decreased on day 110 of gestation in GM maize-fed sows (P¼0·10) and in off-
spring at birth (P¼0·08). Both platelet count (P¼0·07) and mean cell Hb concentration (MCHC; P¼0·05) were decreased on day 110 of
gestation in GM maize-fed sows; however, MCHC tended to be increased in offspring at birth (P¼0·08). There was a minimal effect of
feeding GM maize to sows during gestation and lactation on maternal and offspring serum biochemistry and haematology at birth and
body weight at weaning.
Key words: Maize: Cry1Ab (1 epidopteran-active crystalline protein): Cross-generational effects: GM food: Safety
The genetic modification of crops has led to vast agronomic
improvement and, in turn, rapid uptake of this relatively
new technology. Since the introduction of GM crops in
1996, the land area used for their cultivation has increased
94-fold reaching 160 million hectares worldwide in 2011(1).
As the rate of adoption of GM crops continues to increase,
so too will their consumption by animals reared for food. Con-
sequently, the procurement of exclusively non-GM food ingre-
dients will become increasingly difficult and expensive.
Although numerous beneficial attributes such as resistance
to insect damage or inclement growing conditions are associ-
ated with the genetic modification of crops(1), the inclusion of
GM crops in animal and human food has raised some con-
cerns regarding their safety. Consumer concerns are mostly
related to a perceived risk to health, development of
toxicity, allergenicity of transgenic proteins or the transfer of
antibiotic resistance from the plant to bacteria residing in the
gastrointestinal tract(2). Other concerns are associated with
environmental issues, such as gene transfer from GM crops
to indigenous plants, reducing biodiversity and the influence
of GM crops on non-target species(3–6).
GM crops are subject to rigorous pre-market risk assessment
before authorisation for release onto the European market.
However, unintended consequences associated with the con-
sumption of GM food by a genetically diverse population of
humans and animals cannot adequately be evaluated during
pre-market risk assessment(7). Post-market monitoring is
required to ascertain whether prolonged exposure to GM
food results in responses that have been predicted by pre-
market risk assessment, or to reveal the presence of side
effects that have been previously unpredicted.
Bt MON810 maize is engineered to express the truncated
Cry1Ab toxin from Bacillus thuringiensis, which confers
resistance to the European maize borer. This toxin interacts
*Corresponding author: Dr P. G. Lawlor, fax þ353 25 42340, email peadar.lawlor@teagasc.ie
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BW, body weight; GGT, g-glutamyltransferase;
Hct, haematocrit; MCHC, mean corpuscular Hb concentration; TP, total protein.
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with the target larvae’s intestinal cells, disrupting the intesti-
nal lining leading to death(8–10). However, the toxin is
believed to be non-toxic to mammals, birds, reptiles and
amphibians due to a lack of specific receptors in the intesti-
nal tract(8).
To date, there is a lack of long-term studies conducted with a
large number of animals over several generations with the
objective of evaluating the effects of GM feeds on livestock
species(11). Multigenerational studies evaluating the long-term
effects of feeding GM feed have been confined to sheep(12),
mice(13) and rats(14,15), and have not been conducted to date
in pigs, perhaps the best recognised animal model for human
physiology(16). Results from one multigenerational feeding
study in which mice were fed 33 % NK603 £ MON810 GM
maize compared with non-GM maize concluded that litter size
and weight in the third and fourth litters of continuous breeding
were decreased in the GM maize-fed group(13). However, con-
cerns were raised by researchers as to the validity of this
research due to perceived flaws in the statistical analysis of
the data(17). The study was subsequently withdrawn by the Aus-
trian government and the European Food Safety Authority
Scientific Panel on Genetically Modified Organisms concluded
that ‘on the basis of the data presented the Genetically Modified
Organisms Panel is of the opinion that no conclusions can be
drawn from the report’(18).
The primary objective of the present study was to examine
the cross-generational effects of feeding Bt MON810 maize on
maternal and offspring health in an animal more appropriately
used as a model for humans. The present investigation is part
of a larger study examining the trans-generational effect of
exposure to GM maize on growth and health indicators in
pigs (St Buzoianu, Mc Walsh, MC Rea, et al., unpublished result).
Materials and methods
Animal welfare
The present animal study complied with the European Union
Council Directive 91/630/EEC (outlines minimum standards
for the protection of pigs) and 98/58/EC (concerns the protec-
tion of animals kept for farming purposes) and was approved
by, and a license obtained from, the Irish Department of
Health and Children (licence no. B100/4147). Ethical approval
was obtained from the Teagasc and Waterford Institute of
Technology ethics committees.
Experimental design and diets
A total of twenty-four cross-bred (Large White £ Landrace) nul-
liparous sows and their offspring were used in a 20-week study.
At service, sows (approximately 165 kg) were blocked by body
weight (BW) and service date and randomly assigned to one of
two dietary treatments: (1) non-GM isogenic parent line maize
(Pioneer PR34N43) and (2) GM maize (Pioneer PR34N44
event MON810). Sows were fed the experimental diets from ser-
vice throughout gestation and lactation until litters were weaned
at approximately 28 d post-farrowing (Table 1).
Seeds derived from GM Bt MON810 and non-GM parent
line control maize (PR34N44 and PR34N43, respectively; Pio-
neer Hi-Bred) were grown simultaneously side by side in
Table 1. Composition of sow gestation and lactation diets (fresh weight basis, %)
Gestation Lactation
Ingredients (%) Non-GM GM Non-GM GM
Maize (non-GM) 86·55 – 74·42 –
Maize (GM MON810) – 86·55 – 74·42
Soyabean meal (non-GM) 10·33 10·33 19·30 19·30
Soyabean oil – – 3·02 3·02
Lys HCl (78·8) 0·16 0·16 0·25 0·25
DL-Met – – 0·10 0·10
L-Thr (98) – – 0·06 0·06
Vitamin and mineral premix* 0·10 0·10 0·10 0·10
Salt feed grade 0·40 0·40 0·40 0·40
Dicalcium phosphate 1·36 1·36 1·29 1·29
Limestone flour 1·10 1·10 1·06 1·06
Analysed chemical composition (%)
DM 88·40 87·80 89·50 88·60
Crude protein 11·80 11·00 15·60 15·00
Fat 3·00 3·20 5·90 6·00
Crude fibre 1·70 1·60 1·60 1·90
Ash 4·10 4·30 4·60 4·30
Lys 0·64 0·68 1·01 0·96
Ca† 7·60 7·60 7·50 7·50
P† 6·10 6·10 6·20 6·20
Digestible energy (MJ/kg)† 13·80 13·80 14·50 14·50
* Premix provided per kg of complete diet: Cu, 15 mg; Fe, 70 mg; Mn, 62 mg; Zn, 80 mg; I, 0·6 mg; Se, 0·2 mg; retinyl acet-
ate, 3.44 mg; cholecalciferol, 25mg; DL-a-tocopheryl acetate, 100 mg vitamin K, 2 mg; vitamin B12, 15mg; riboflavin,
5 mg; nicotinic acid, 12 mg; pantothenic acid, 10 mg; choline chloride, 500 mg; biotin, 200 mg; folic acid, 5 mg;
vitamin B1, 2 mg; vitamin B6, 3 mg.
† Calculated values.
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2007 in Valtierra, Navarra, Spain by independent tillage farm-
ers. GM and non-GM control maize were purchased by the
authors from the tillage farmers for use in the present
animal study. Samples from GM and non-GM maize were
tested for chemical, amino acid and carbohydrate composition
as well as for the presence of the cry1Ab gene, pesticide con-
taminants and mycotoxins, as previously described by Walsh
et al.(19).
All diets were manufactured and analysed for chemical
composition and amino acid concentration as previously
described by Walsh et al.(19). Sampling of the diets was con-
ducted in accordance with international guidelines(20). All
diets were formulated to meet or exceed the National
Research Council requirements(21) for pigs at the relevant
stage of the production cycle. From selection at 100 kg until
service, gilts were fed a non-GM gilt developer diet
(13·67 MJ digestable energy/kg, 6·0 g lysine/kg). Sows were
fed either non-GM or GM maize-based gestation diets from
service until farrowing (approximately 115 d). Following
farrowing, sows were fed either non-GM or GM maize-based
lactation diets until litters were weaned (approximately 28 d
of age). Creep feed was not offered to suckling piglets.
Housing and management
Gilts were purchased from Hermitage AI as weanling pigs
(approximately 28 d old) and raised to approximately 165 kg
in the Moorepark pig unit. During this time, gilts received
diets that were free of GM ingredients. At approximately
100 kg, gilts were selected for service based on weight and
desirable conformation traits (leg conformation and nipple
number and position) and housed in gilt accommodation
until 1 week before service. Gilts were restrictively fed
during this time, receiving 2·5 kg of gilt developer diet per d.
Synchronisation of sow oestrus was achieved by administering
20 mg of altrenogest (Regumate; Intervet/Schering-Plough
Animal Health) per gilt in feed for 18 d. Following adminis-
tration of altrenogest, the gilts were moved to the service
area where they remained until service. A sexually mature
boar was housed in the room to stimulate the gilts to come
into oestrus. At 9 d before predicted oestrus, the gilts were
flush fed the gilt developer diet (4 kg/d). Gilts were insemi-
nated with pooled semen from five Hylean MaxGroe boars
(Hermitage AI) as soon as oestrus was detected and again
24 h later. After service, gilts were transferred to dry sow
accommodation and were penned individually in basket
stalls (2·4 m £ 0·6 m; O’Donovan Engineering) until day 110
of gestation. Environmental temperature was maintained
between 20 and 228C and gilts had ad libitum access to
water through a single nipple drinker per pen (Arato).
Verification of pregnancy was carried out 28 d after service
using an ultrasound scanner (Oviscan 4 BCF Technology Lim-
ited). Gilts found not to be pregnant at the ultrasound scan or
at any other time point (exhibiting heat or following abortion)
were removed from the study. On days 74 and 99 of gestation,
gilts were routinely vaccinated against Escherichia coli (Por-
coli Diluvac Forte; Intervet/Schering-Plough Animal Health).
Deworming of gilts was performed on day 110 of gestation
by administering Zerofen 4 % powder (Chanelle Animal
Health Limited) in feed (0.125 g/kg BW).
From day 110 of gestation until weaning, gilts were accom-
modated in three farrowing rooms with ten pens per room.
National Pig Development company-type farrowing crates
(O’Donovan Engineering) were used. Environmental
temperature was maintained at 208C except around farrowing
when the temperature was increased to 248C for 48 h. The
dietary treatments were equally represented in each room to
avoid additional variation due to environment. Gilts were
fed 2 kg/d immediately post-farrowing and feed allowance
was incrementally increased by 500 g/d until day 7 post-far-
rowing when sows were feeding ad libitum. Gilts had
access to feed from an ad libitum feeder (Daltec A/S) and
unlimited access to water through a single nipple waterer
(Arato), and supplemental water was provided by lever
valve where necessary. Care was taken to minimise feed
wastage and any soiled or stale feed was removed and
accounted for. On day 114 of gestation, gilts were treated
with 2 ml of Enzaprost (5 mg/ml; CEVA Animal Health Limited)
to induce farrowing 24–36 h later.
Body weight and back-fat depth
Back-fat depth and BW of sows were recorded at service, on
days 56 and 110 of gestation and at weaning. Back-fat depth
was recorded at the P2 position (65 mm down from the mid-
line, at the level of the head of the last rib), using a Renco
Lean Meater (Renco Corporation).
Variables measured at farrowing
Individual BW of piglets in all litters was recorded at birth and
weaning, and average daily gain was calculated during the
suckling period. At farrowing, the fourth piglet born alive
from each litter (twelve per treatment) was killed by captive
bolt stunning followed by exsanguination. Blood samples
were taken for haematology and biochemical analysis as out-
lined below. Heart, kidneys, spleen and liver were removed,
trimmed of any superficial fat or blood, blotted dry and
weighed.
Blood sampling and analysis
Blood samples were collected from the external jugular vein
of sows (twelve per treatment) before service, on days
28 and 110 of gestation and on day 28 of lactation for serum
biochemical analysis and haematology. Blood samples for
serum biochemistry analysis were collected in evacuated col-
lection tubes containing a silica clotting activator (BD Vacutai-
ner Systems) and allowed to clot at room temperature for
2–3 h before centrifugation (1300g for 10 min). Serum was
collected and stored at 2208C for subsequent biochemical
analysis. Serum samples were analysed for aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
g-glutamyltransferase (GGT), alkaline phosphatase (ALP),
creatinine, urea and total protein (TP) as previously described
by Buzoianu et al.(22).
Feeding GM Bt maize to sows 875
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Whole blood samples were collected in evacuated K2EDTA
blood collection tubes (Vacuette, Greiner Bio One Limited)
and stored at room temperature before haematological anal-
ysis which was performed within 6 h of collection. Whole
blood samples were analysed using a Beckman Coulter
Ac T Diff haematology analyser (Beckman Coulter Limited).
The following parameters were determined: number of eryth-
rocytes, Hb concentration, haematocrit (Hct), mean corpuscu-
lar volume, mean corpuscular Hb, mean corpuscular Hb
concentration (MCHC), red cell distribution width, number
of platelets and mean platelet volume. Samples were analysed
according to the manufacturer’s instructions and general hae-
matology recommendations(23).
Statistical analysis
Sow and offspring growth performance data were analysed as
a complete randomised block design using the general linear
model procedure of SAS(24) (SAS Institute Inc.) with pig used
as the experimental unit. Treatment effect was tested against
residual error terms with initial BW and service date as block-
ing factors. Sow BW, body composition and offspring growth
performance, blood biochemistry, and haematology were ana-
lysed as a one-factor ANOVA using the general linear model
procedure of SAS. Organ weights were also analysed as a
one-factor ANOVA using the general linear model procedure
of SAS with birth weight as a covariate in the model. Sow
serum biochemistry data and haematology were analysed as
a repeated measure using the MIXED procedure of SAS with
sampling day as the repeated variable. Simple main effects
were obtained using the ‘slice’ option in SAS. Mean separation
was performed using the Tukey–Kramer adjustment for mul-
tiple comparisons and values recorded before service were
used as a covariate in the model. Fixed effects included treat-
ment and sampling day, while block effects were included as a
random effect in the model. The number of piglets born alive
per litter was used as a covariate in the analysis of erythrocyte
count, Hb concentration and Hct. For all tests, the level of sig-
nificance was P,0·05 and tendencies were reported for
0·05,P,0·10.
Results
Analysis of non-GM and GM diets
Similar chemical and amino acid compositions were observed
between the non-GM and GM diets (Table 1).
Effect of feeding diets containing non-GM or GM maize
on body weight, body composition of sows and growth
rate of offspring
Sows fed the GM maize-based diets were heavier on day 56 of
gestation compared with sows fed the non-GM maize diets
(P¼0·05; Table 2). On day 110 of gestation, there was no
difference in BW between the treatments. There was no differ-
ence in back-fat depth between the treatments at any time
during the study. The average daily gain of piglets or the vari-
ation in average daily gain within litter during the suckling
period was not affected by feeding GM maize to sows. Piglets
from GM maize-fed sows tended to be lighter at weaning than
piglets from non-GM maize-fed sows (P¼0·08). Litter weaning
weight or the within-litter variation in piglet weaning weight
was not affected by feeding GM maize to sows. There was
no difference in pre-weaning mortality levels per litter
between the treatments.
Table 2. Effect of feeding Bt (MON810) maize to sows during gestation and lactation on sow body weight and back-
fat depth and offspring pre-weaning growth performance
(Mean values with their standard errors, n 12)
Non-GM maize GM maize
Treatment Mean Mean SE P
Sow performance
Body weight at service (kg) 164·3 165·2 0·40 NS
Body weight at day 56 of gestation (kg) 193·8 197·8 1·20 *
Body weight at day 110 of gestation (kg) 222·2 227·1 2·38 NS
Back-fat depth at service (mm) 18·5 17·4 0·84 NS
Back-fat depth at day 56 of gestation (mm) 18·9 18·7 0·80 NS
Back-fat depth at day 110 of gestation (mm) 18·7 18·9 0·56 NS
Piglet growth performance during lactation
Mean birth weight (kg)‡ 1·45 1·33
ADG (g/d) 229·7 206·4 10·12 NS
Variation in ADG (%) 17·5 17·7 2·15 NS
Number of piglets weaned/sow 10·6 11·9 0·76 NS
Mean weaning weight (kg) 7·65 6·90 0·286 †
Litter weaning weight (kg) 79·8 81·2 6·49 NS
Variation in weaning weight (%) 17·5 15·6 1·75 NS
Pre-weaning mortality (number of pigs/litter) 1·05 1·42 0·248 NS
ADG, average daily gain.
* Mean values were significantly different between the two treatments (P,0·05).
† Mean values tended to be different between the two treatments (P,0·10).
‡ No statistical analysis was conducted on piglet birth weight due to inadequate replication to detect statistical differences.
M. C. Walsh et al.876
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Effect of feeding the non-GM and GM maize diets to sows
during gestation and lactation on serum biochemistry
There tended to be a treatment £ time interaction (P¼0·08) for
TP in serum (Table 3). On day 28 of lactation, the TP concen-
tration in the serum of GM maize-fed sows tended to be
lower than in sows fed the non-GM maize diets (P¼0·10). On
day 110 of gestation, sows fed GM maize tended to have
lower serum urea compared with non-GM maize-fed sows
(P¼0·09), and serum urea was found to increase during ges-
tation and lactation (P,0·001). There tended to be a
treatment £ time interaction (P¼0·09) for serum creatinine.
Serum creatinine was higher in GM maize-fed sows on day 28
of lactation compared with non-GM maize-fed sows
(P,0·05). Serum creatinine increased during gestation but
had decreased again by day 28 of lactation (P,0·001). There
was no effect of treatment on ALT or ALP; however, both par-
ameters decreased over time (P,0·001). On day 28 of lactation,
GGT concentration tended to be greater in the serum of GM
maize-fed sows compared with non-GM maize-fed sows
(P¼0·07). The concentration of GGT in serum decreased
during gestation but serum concentrations were higher on
day 28 of lactation than on day 28 of gestation (P,0·001).
There was no effect of treatment on serum AST during the
study; however, the concentration of AST decreased during ges-
tation and increased again during lactation (P,0·01).
Effect of feeding the non-GM and GM maize diets to sows
during gestation and lactation on sow haematology
Throughout the study, there was no difference in erythrocyte
count between sows fed GM or non-GM maize during ges-
tation and lactation (Table 4). Erythrocyte count decreased
for all sows during gestation and lactation (P,0·001). Like-
wise, both Hb concentration and Hct were not different
between the treatments throughout the study. Both Hb con-
centration and Hct also decreased over time for both treat-
ments (P,0·001). There was no effect of treatment on mean
corpuscular volume. An increase over time was found for
mean corpuscular Hb and mean corpuscular volume
(P,0·001). On day 110 of gestation, feeding GM maize
Table 3. Effect of feeding Bt (MON810) maize to sows during gestation and lactation on serum biochemistry
(Mean values with their standard errors, n 12)
Treatment P
Days Non-GM maize GM maize Mean SE Treatment Time Treatment£ time
Serum total protein (g/l)
Day 28 of gestation 75·0 74·0 74·5 1·65 NS
Day 110 of gestation 73·5 74·8 74·2 1·62 NS
Day 28 of lactation 75·2 71·9 73·5 1·62 †
Mean 74·6 73·6 1·41 NS NS †
Serum urea (mmol/l)
Day 28 of gestation 2·20 2·10 2·11 0·207 NS
Day 110 of gestation 2·54 2·04 2·29 0·207 †
Day 28 of lactation 4·23 4·26 4·29 0·216 NS
Mean 3·02 2·77 0·142 NS *** NS
Serum creatinine (mmol/l)
Day 28 of gestation 142·6 141·6 142·1 4·13 NS
Day 110 of gestation 195·6 205·2 200·4 4·13 NS
Day 28 of lactation 156·1 169·3 162·7 4·28 *
Mean 164·8 172·0 3·15 NS *** †
Alanine aminotransferase (units/l)
Day 28 of gestation 33·6 36·8 35·2 1·54 NS
Day 110 of gestation 29·3 30·6 29·9 1·54 NS
Day 28 of lactation 27·8 27·2 27·0 1·61 NS
Mean 29·9 31·5 1·04 NS *** NS
Alkaline phosphatase (units/l)
Day 28 of gestation 73·7 73·4 73·6 3·55 NS
Day 110 of gestation 57·8 57·7 57·8 3·55 NS
Day 28 of lactation 47·5 45·8 46·7 3·70 NS
Mean 59·7 59·0 2·38 NS *** NS
g-Glutamyltransferase (units/l)
Day 28 of gestation 51·1 55·4 53·1 3·39 NS
Day 110 of gestation 47·5 47·8 47·7 3·39 NS
Day 28 of lactation 61·1 70·6 65·8 3·50 †
Mean 53·3 57·9 2·69 NS *** NS
Aspartate aminotransferase (units/l)
Day 28 of gestation 22·1 21·3 21·7 1·99 NS
Day 110 of gestation 20·7 18·3 19·5 1·99 NS
Day 28 of lactation 24·2 27·6 25·9 2·08 NS
Mean 22·3 22·4 1·47 NS ** NS
Mean values were significantly different between the two treatments: *P,0·05, **P,0·01, ***P,0·001.
† Mean values tended to be different between the two treatments (P,0·10).
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resulted in lower MCHC in blood (P¼0·05) compared with
non-GM maize. MCHC in blood decreased during gestation
and lactation (P,0·001). There was no effect of feeding GM
maize on red cell distribution width in blood and red cell dis-
tribution width was found to increase over time (P,0·01).
There tended to be a treatment £ time interaction (P¼0·07)
for blood platelet count. On day 110 of gestation, there
tended (P¼0·10) to be fewer platelets in the blood of GM
maize-fed sows than in non-GM maize-fed sows. There was
no effect of treatment on mean platelet volume in blood and
mean platelet volume was found to increase during gestation
but decrease during lactation (P,0·001).
Effect of feeding the non-GM and GM maize diets to sows
during gestation on serum biochemistry, haematology and
organ weight of offspring at birth
There was no effect of feeding GM maize to sows during ges-
tation on the heart, liver, kidneys and spleen weight of off-
spring at birth (Table 5). TP and creatinine in the serum of
offspring at birth were unaffected by the treatment; however,
the offspring of sows fed GM maize tended to have lower
serum urea than the offspring from sows fed non-GM maize
(P¼0·08). The concentration of the liver enzymes ALT, AST,
GGT and ALP in the serum of offspring at birth was not
Table 4. Effect of feeding Bt (MON810) maize to sows during gestation and lactation on haematology
(Mean values with their standard errors, n 12)
Treatment P
Days Non-GM maize GM maize Mean SE Treatment Time Treatment£ time
Erythrocytes (1 000 000/ml)
Day 28 of gestation 7·79 7·68 7·73 0·128 NS
Day 110 of gestation 6·60 6·64 6·62 0·111 NS
Day 28 of lactation 5·85 5·67 5·76 0·114 NS
Mean 6·74 6·67 0·096 NS *** NS
Hb (g/l)
Day 28 of gestation 156 151 153 2·1 NS
Day 110 of gestation 132 131 132 2·1 NS
Day 28 of lactation 118 112 115 2·2 NS
Mean 135 131 1·4 NS *** NS
Haematocrit (litres/l)
Day 28 of gestation 0·443 0·442 0·443 0·0080 NS
Day 110 of gestation 0·384 0·386 0·385 0·0065 NS
Day 28 of lactation 0·348 0·334 0·341 0·0068 NS
Mean 0·391 0·387 0·0049 NS *** NS
MCV (fl)
Day 28 of gestation 56·5 57·2 56·8 0·45 NS
Day 110 of gestation 57·8 58·1 57·9 0·45 NS
Day 28 of lactation 59·0 59·0 59·0 0·47 NS
Mean 57·7 58·1 0·34 NS *** NS
MCH (g/l)
Day 28 of gestation 196 199 198 3·1 NS
Day 110 of gestation 202 200 201 2·8 NS
Day 28 of lactation 203 200 201 2·8 NS
Mean 201 200 2·5 NS NS NS
MCHC (%)
Day 28 of gestation 34·4 34·3 34·4 0·16 NS
Day 110 of gestation 34·6 34·1 34·3 0·13 *
Day 28 of lactation 33·8 33·8 33·8 0·13 NS
Mean 34·3 34·1 0·09 NS *** NS
RDW (%)
Day 28 of gestation 18·0 17·7 17·8 0·25 NS
Day 110 of gestation 17·6 17·8 17·7 0·25 NS
Day 28 of lactation 18·2 18·3 18·3 0·26 NS
Mean 17·9 17·9 0·20 NS ** NS
Platelets (1000/ml)
Day 28 of gestation 252·6 269·6 261·1 24·0 NS
Day 110 of gestation 264·1 215·8 239·9 23·1 †
Day 28 of lactation 348·3 383·0 365·7 24·0 NS
Mean 288·3 289·5 17·9 NS NS †
MPV (fl)
Day 28 of gestation 7·99 8·17 8·08 0·15 NS
Day 110 of gestation 9·12 8·93 9·02 0·15 NS
Day 28 of lactation 8·47 8·66 8·56 0·16 NS
Mean 8·52 8·59 0·10 NS *** NS
MCV, mean corpuscular volume; MCH, mean corpuscular Hb; MCHC, mean corpuscular Hb concentration; RDW, red cell distribution width; MPV, mean platelet volume.
Mean values were significantly different between the two treatments: *P,0·05, **P,0·01, ***P,0·001.
† Mean values tended to be different between the two treatments (P,0·10).
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different between the treatments. There was no effect of treat-
ment on erythrocyte count, Hb, Hct, mean corpuscular
volume, mean corpuscular Hb, red cell distribution width, pla-
telet count and mean platelet volume measured in the blood
of offspring at birth. The offspring of sows fed GM maize
tended to have a higher MCHC in blood than the offspring
from non-GM maize-fed sows (P¼0·08).
Discussion
This is the first study in pigs to examine the transgenerational
effect of GM maize exposure on the health of both dam and off-
spring. The results from the present study indicate that feeding
GM maize to sows during gestation does not affect body compo-
sition as determined by back-fat depth, and differences in BW
observed between the treatments at mid-gestation were not pre-
sent in late gestation. Parallel to the present findings, Trabalza-
Marinucci et al.(12) found that feeding Bt176 maize to sheep
over a 3-year period had no effect on BWor the body condition
score. A study in which cows were fed Bt MON810 maize over
two successive lactations revealed a decrease in body condition
score and weight during the second lactation in the GM maize-
fed group(25). Steinke et al.(25) concluded that the observed
differences in body condition score and weight in cows could
be attributed to biological variation rather than GM maize
exposure as values were still within the normal biological
range for these animals.
The present study was not designed to evaluate the effects
of GM maize feeding on sow reproductive performance but
rather on sow and offspring growth and health. Additional
studies with much greater replication are necessary to assess
the effects of GM maize on the reproductive performance of
sows. However, although not thought to be related to treat-
ment, the present study found that GM maize-fed sows gave
birth to numerically more live-born piglets (2·5 piglets/litter)
than non-GM maize-fed sows. As a consequence of numeri-
cally more piglets born to and reared by GM maize-fed sows
(1·3 extra piglets weaned/litter), the weaning weight of piglets
from GM maize-fed sows was less than that of piglets from
non-GM maize-fed sows. As piglets were not offered creep
feed during the lactation period, the additional suckling pigs
would have placed increased demand on the sows’ limited
milk supply, thereby reducing growth.
Similar to the present findings, results from a sheep study
found that feeding Bt176 maize over a 3-year period had
no effect on the mortality or growth rate of lambs to
weaning(12). The diet of lambs was supplemented before
weaning with a mixture of non-GM cereals and faba beans.
Likewise, a study on feeding Bt maize to rats found that
birth rate and the survival of offspring were not affected by
treatment(15).
We previously reported no effect of short-term exposure of
Bt MON810 maize on serum TP, creatinine, urea or the liver
enzymes AST, ALT and GGT in weanling pigs(19). The results
from the present study found that feeding GM maize to
sows during gestation and lactation resulted in increased
serum creatinine and GGT concentration and reduced serum
TP at the end of lactation and decreased serum urea at the
Table 5. Effect of feeding Bt (MON810) maize to sows during gestation on offspring organ weight, blood biochemistry
and haematology at birth
(Mean values with their standard errors, n 12)
Non-GM maize GM maize
Treatment Mean Mean SE P
Organ weight (g)†
Heart 9·85 9·84 0·340 NS
Kidneys 9·88 9·77 0·539 NS
Spleen 1·28 1·16 0·069 NS
Liver 39·7 36·9 1·93 NS
Serum biochemistry
Serum total protein (g/l) 22·2 22·8 0·79 NS
Serum urea (mmol/l) 3·08 2·41 0·249 *
Serum creatinine (mmol/l) 161·3 156·3 12·52 NS
Alanine aminotransferase (units/l) 11·1 13·0 1·04 NS
Aspartate aminotransferase (units/l) 60·9 70·8 18·28 NS
g-Glutamyltransferase (units/l) 55·2 64·3 4·77 NS
Alkaline phosphatase (units/l) 1968·6 2087·7 306·59 NS
Haematology
Erythrocytes (1 000 000/ml) 5·79 4·50 0·707 NS
Hb (g/l) 109·2 80·5 19·04 NS
Haematocrit (litres/l) 1·73 5·33 2·56 NS
MCV (fl) 81·5 62·5 14·49 NS
MCH (g/l) 191·3 220·4 13·46 NS
MCHC (%) 29·54 30·50 0·355 *
RDW (%) 18·44 18·31 0·453 NS
Platelets (1000/ml) 154·2 117·4 22·45 NS
MPV (fl) 9·65 9·56 0·361 NS
MCV, mean corpuscular volume; MCH, mean corpuscular Hb; MCHC, mean corpuscular Hb concentration; RDW, red cell distribution
width; MPV, mean platelet volume.
* Mean values tended to be different between the two treatments (P,0·10).
† Organ weight data were analysed using birth weight as a covariate in the model.
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end of gestation. However, the measured values were all
within the normal reference range for pigs during these repro-
ductive stages(26), and with the exception of serum creatinine
none was significantly different. Likewise, offspring from GM
maize-fed sows also had decreased serum urea concentrations
at birth compared with offspring from non-GM maize-fed
sows; however, liver enzyme activity and liver weight at
birth were not different between the treatments. Liver dysfunc-
tion is characterised by increased GGT concentration; how-
ever, this must also be accompanied by a 10–70-fold
increase in AST and a 5–10-fold increase in ALP, neither of
which were obseved in sows or offspring in the present
study(27,28). Similar to the present findings, at the end of lacta-
tion, ewes fed Bt176 maize also experienced an increase in
GGT concentration in serum; however, there were no effects
on serum creatinine, TP, urea, ALP or AST(12). In agreement
with the present findings, serum TP was found to be lower
in rats fed Bt maize during a three-generation study(15). Kilic
& Akay(15) also reported a decrease in plasma creatinine,
which was in contrast to the present results. Likewise, Poulsen
et al.(29) observed a lower creatinine concentration together
with increased plasma activity of ALT in female rats fed GM
rice. The change in sow serum urea documented in the pre-
sent study was transient and isolated to day 110 of gestation
which questions the biological relevance of this change, but
this may account for the decrease observed in serum urea in
their offspring. Kidney dysfunction is characterised by elev-
ated serum urea and creatinine, low serum TP(27,30,31) and
increased urinary protein:creatinine ratio(30). While urinary
protein and creatinine were not measured during the present
study, serum TP was reduced and serum creatinine was
increased in sows fed GM maize at the end of lactation in
the present study. Nonetheless, there was no change in
serum urea and the observed changes in creatinine and TP
at day 28 of lactation were small and remained within the
normal reference range for these parameters in sows during
gestation and lactation. Offspring serum TP, creatinine and
kidney weight were not different regardless of the dietary
treatment of their dam. Therefore, there is a lack of evidence
that changes in blood biochemistry observed in sows during
the present study conform to a pattern indicative of either
liver or kidney dysfunction or that these changes have any
major effect on the organ function of their offspring at birth.
In the present study, feeding GM maize to sows had no
effect on erythrocyte count, Hb concentration and Hct
during gestation and lactation. Likewise, feeding GM maize
to sows had no effect on haematological parameters of their
offspring as no treatment differences were detected in erythro-
cyte count, Hb concentration and Hct. Similar to the present
findings, a rat study in which haematological parameters
were measured in response to feeding GM rice expressing
Cry1Ab found no effect of treatment(32). In contrast, however,
Trabalza-Marinucci et al.(12) reported an increase in Hb in
sheep fed Bt176 maize. The trend for a decrease in platelet
count and a decrease in MCHC observed at the end of ges-
tation in GM maize-fed sows in the present study was transient
and minimal, and is unlikely to be of biological significance.
Offspring from sows fed GM maize were found to have a
tendency for an increase in MCHC at birth; however, this
was not accompanied by any other changes in haematology
and was contrary to the decrease in MCHC found in their
dams. Further research is ongoing by our research group to
establish whether changes observed in the offspring of GM
maize-fed sows at birth will affect the lifetime performance
of these pig. This will help to determine the biological
relevance of these changes.
In the present study, the effects of feeding GM maize were
evaluated based on comparisons made between GM maize
and its isogenic counterpart. Subsequent work conducted by
our group using another GM ingredient (MC Walsh, St
Buzoianu, D Reiner, et al., unpublished results) included
other conventional varieties in safety evaluation. Differences
were observed in some of the physiological parameters
measured between the two conventional non-GM varieties.
These findings highlight the importance of including other
conventional varieties when evaluating the effects of a GM
ingredient.
In conclusion, feeding Bt MON810 maize to sows during
gestation and lactation had no effect on the back-fat depth
of sows, and the increase in BW on day 56 of gestation was
not observed subsequently. Changes in sow blood biochemis-
try during the study in response to feeding GM maize did not
conform to a pattern indicative of organ dysfunction and were
within the normal reference range for sows. No differences in
sow haematological parameters were observed between the
treatments, with the exception of a tendency for a transient
decrease in platelet count and a decrease in MCHC on day
110 of gestation in response to feeding GM maize. There
was a minimal effect of feeding GM maize to sows during ges-
tation and lactation on offspring serum biochemistry and hae-
matology at birth and BW at weaning. However, further
studies are currently underway to evaluate the lifetime
health and growth performance of offspring from Bt
MON810 maize-fed sows.
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